JPRN-UMIN000001050
Completed
Phase 2
A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07) - A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with lymphoma (R-MEP07)
Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)0 sites40 target enrollmentMarch 1, 2008
ConditionsDiffuse large B-cell lymphoma
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Diffuse large B-cell lymphoma
- Sponsor
- Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) CNS involvement 2\) History of glaucoma 3\) History of severe drug allergy 4\) Active infectious diseases 5\) HIV or HTLV\-1 positive 6\) HBs antigen or HCV antibody positive 7\) Significant complications which include cardiac dysfunction, liver cirrhosis, uncontrolled diabetes, renal failure 8\) Interstitial pneumonitis or fibrosis 9\) History of other active malignancy 10\) Severe mental disorder 11\) Regular use of systemic steroids 12\) Inadequate physical condition, as diagnosed by primary physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 2
Japanese Phase II Study of Rituximab in combination with FC-chemotherapy in patients with previously untreated Chronic Lymphocytic LeukemiaJPRN-jRCT2080222236ZENYAKU KOGYO CO., LTD.6
Completed
Not Applicable
Phase II study of Rituximab in Patients with Systemic Lupus ErythematosusSystemic lupus erythematosusJPRN-UMIN000000762Zenyaku Kogyo Co., Ltd.70
Active, not recruiting
Phase 1
Study of Rituximab and Ibrutinib (RI) versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as initial therapy for Waldenström's macroglobulinaemiaWaldenström's macroglobulinaemiaTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2019-001261-33-GBniversity College London148
Active, not recruiting
Phase 1
Multicenter study of phase II with Rituximab, cyclophosphamide, doxorubicin liposomal (Myocet), vincristine, Prednisone, (R-COMP) in diffuse Non-Hodgkin`s lymphoma, large B cells of the cardiopathic patient - HEART01Diffuse Non-Hodgkin`s lymphoma, large B cells of the cardiopathic patientMedDRA version: 9.1Level: PTClassification code 10012818EUCTR2009-012143-42-ITIIL INTERGRUPPO ITALIANO LINFOMI ONLUS50
Active, not recruiting
Phase 1
Evaluation of Rituximab-based Regimen Compared to Conventional Therapeutic Strategy For Remission Induction In Patients With Newly-Diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis. Prospective, randomized, controlled, double-blind study. - REOVASEUCTR2016-000275-25-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)108